Isotope-Labeled Compounds
Research Areas
Products Related to Isotope-Labeled Compounds(1212)
- GC91570Stearic Acid-d5CAS: 211443-83-3Purity: >99.00%
Stearic acid-d5 is intended for use as an internal standard for the quantification of stearic acid by GC- or LC-MS.
- GC91589Thymine-13C5,15N2CAS: 2483830-13-1Purity: >98.00%
Thymine-13C5,15N2 is intended for use as an internal standard for the quantification of thymine by GC- or LC-MS.
- GC91607β-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation)CAS: 2747917-90-2Purity: >99.00%
β-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation) is intended for use as an internal standard for the quantification of β-hydroxythiofentanyl by GC- or LC-MS.
- GC916201-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PACAS: 2830282-77-2Purity: >99.00%
1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9 LPA) is intended for use as an internal standard for the quantification of 1-palmitoyl LPA by GC- or LC-MS.
- GC91665(±)-Methadone-d3CAS: 60263-63-0Purity: >99.00%
(±)-Methadone-d3 is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS.
- GC91666(±)-Methadone-d3 (CRM)CAS: 60263-63-0
(±)-Methadone-d3 (CRM) is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS.
- GC91683Lorazepam-d4 (CRM)CAS: 84344-15-0
Lorazepam-d4 (CRM) is intended for use as an internal standard for the quantification of lorazepam .
- GC91699Adenine-15N5 (hydrochloride hydrate)Purity: >98.00%
Adenine-15N5 is intended for use as an internal standard for the quantification of adenine by GC- or LC-MS.
- GC9170213C6-4-Nitrophenylhydrazine (hydrochloride)Purity: >95.00%
13C6-4-Nitrophenylhydrazine is intended for use as an internal standard for the quantification of 4-nitrophenylhydrazine by GC- or LC-MS.
- GC91705Etomidate-d5Purity: >99.00%
Etomidate-d5 is intended for use as an internal standard for the quantification of etomidate by GC- or LC-MS.
- GC91710α-Pyrrolidinohexanophenone-d8 (hydrochloride) (CRM)
α-Pyrrolidinohexanophenone-d8 (hydrochloride) (CRM) is intended for use as an internal standard for the quantification of α-pyrrolidinohexanophenone by GC- or LC-MS.
- GC91718Aeruginascin-d3 (CRM)
Aeruginascin-d3 is intended for use as an internal standard for the quantification of aeruginascin by GC- or LC-MS.
- GC9172113C6-6-PPD-quinonePurity: >98.00%
13C6-6-PPD-quinone is intended for use as an internal standard for the quantification of 6-PPD-quinone by GC- or LC-MS.
- GC91729Phytosphingosine-d7Purity: >99.00%
Phytosphingosine-d7 is intended for use as an internal standard for the quantification of phytosphingosine by GC- or LC-MS.
- GC917319(S)-Hexahydrocannabinol-d9Purity: >99.00%
9(S)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(S)-hexahydrocannabinol by GC- or LC-MS.
- GC917329(R)-Hexahydrocannabinol-d9Purity: >99.00%
9(R)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(R)-hexahydrocannabinol by GC- or LC-MS.
- GC91736(-)-11-hydroxy-δ8-THC-d3 (exempt preparation)Purity: >99.00%
(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS.
- GC91739ADB-BUTINACA-d9 (CRM)
ADB-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-BUTINACA by GC- or LC-MS.
- GC9174314(S)-HDHA-d5Purity: >99.00%
14(S)-HDHA-d5 is intended for use as an internal standard for the quantification of 14(S)-HDHA by GC- or LC-MS.
- GC91744MDMB-BUTINACA-d9Purity: >99.00%
MDMB-BUTINACA-d9 is intended for use as an internal standard for the quantification of MDMB-BUTINACA by GC- or LC-MS.
- GC91750MDMB-4en-PINACA-d4 (CRM)
MDMB-4en-PINACA-d4 (CRM) is intended for use as an internal standard for the quantification of MDMB-4en-PINACA in a drug discrimination test and induces hypothermia in mice.
- GC91752Iloprost-d4Purity: >99.00%
Iloprost-d4 is intended for use as an internal standard for the quantification of iloprost by GC- or LC-MS.
- GC91755MDMB-PICA-d9Purity: >99.00%
MDMB-PICA-d9 is intended for use as an internal standard for the quantification of MDMB-PICA by GC- or LC-MS.
- GC91756Prednisolone-d7Purity: >99.00%
Prednisolone-d7 is intended for use as an internal standard for the quantification of prednisolone by GC- or LC-MS.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC91570 | Stearic Acid-d5 | 211443-83-3 | >99.00% | |
Stearic acid-d5 is intended for use as an internal standard for the quantification of stearic acid by GC- or LC-MS. | ||||
| GC91589 | Thymine-13C5,15N2 | 2483830-13-1 | >98.00% | |
Thymine-13C5,15N2 is intended for use as an internal standard for the quantification of thymine by GC- or LC-MS. | ||||
| GC91607 | β-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation) | 2747917-90-2 | >99.00% | |
β-Hydroxythiofentanyl-d5 (hydrochloride) (exempt preparation) is intended for use as an internal standard for the quantification of β-hydroxythiofentanyl by GC- or LC-MS. | ||||
| GC91620 | 1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA | 2830282-77-2 | >99.00% | |
1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9 LPA) is intended for use as an internal standard for the quantification of 1-palmitoyl LPA by GC- or LC-MS. | ||||
| GC91665 | (±)-Methadone-d3 | 60263-63-0 | >99.00% | |
(±)-Methadone-d3 is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS. | ||||
| GC91666 | (±)-Methadone-d3 (CRM) | 60263-63-0 | - | |
(±)-Methadone-d3 (CRM) is intended for use as an internal standard for the quantification of methadone by GC- or LC-MS. | ||||
| GC91683 | Lorazepam-d4 (CRM) | 84344-15-0 | - | |
Lorazepam-d4 (CRM) is intended for use as an internal standard for the quantification of lorazepam . | ||||
| GC91699 | Adenine-15N5 (hydrochloride hydrate) | - | >98.00% | |
Adenine-15N5 is intended for use as an internal standard for the quantification of adenine by GC- or LC-MS. | ||||
| GC91702 | 13C6-4-Nitrophenylhydrazine (hydrochloride) | - | >95.00% | |
13C6-4-Nitrophenylhydrazine is intended for use as an internal standard for the quantification of 4-nitrophenylhydrazine by GC- or LC-MS. | ||||
| GC91705 | Etomidate-d5 | - | >99.00% | |
Etomidate-d5 is intended for use as an internal standard for the quantification of etomidate by GC- or LC-MS. | ||||
| GC91710 | α-Pyrrolidinohexanophenone-d8 (hydrochloride) (CRM) | - | - | |
α-Pyrrolidinohexanophenone-d8 (hydrochloride) (CRM) is intended for use as an internal standard for the quantification of α-pyrrolidinohexanophenone by GC- or LC-MS. | ||||
| GC91718 | Aeruginascin-d3 (CRM) | - | - | |
Aeruginascin-d3 is intended for use as an internal standard for the quantification of aeruginascin by GC- or LC-MS. | ||||
| GC91721 | 13C6-6-PPD-quinone | - | >98.00% | |
13C6-6-PPD-quinone is intended for use as an internal standard for the quantification of 6-PPD-quinone by GC- or LC-MS. | ||||
| GC91729 | Phytosphingosine-d7 | - | >99.00% | |
Phytosphingosine-d7 is intended for use as an internal standard for the quantification of phytosphingosine by GC- or LC-MS. | ||||
| GC91731 | 9(S)-Hexahydrocannabinol-d9 | - | >99.00% | |
9(S)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(S)-hexahydrocannabinol by GC- or LC-MS. | ||||
| GC91732 | 9(R)-Hexahydrocannabinol-d9 | - | >99.00% | |
9(R)-Hexahydrocannabinol-d9 is intended for use as an internal standard for the quantification of 9(R)-hexahydrocannabinol by GC- or LC-MS. | ||||
| GC91736 | (-)-11-hydroxy-δ8-THC-d3 (exempt preparation) | - | >99.00% | |
(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS. | ||||
| GC91739 | ADB-BUTINACA-d9 (CRM) | - | - | |
ADB-BUTINACA-d9 (CRM) is intended for use as an internal standard for the quantification of ADB-BUTINACA by GC- or LC-MS. | ||||
| GC91743 | 14(S)-HDHA-d5 | - | >99.00% | |
14(S)-HDHA-d5 is intended for use as an internal standard for the quantification of 14(S)-HDHA by GC- or LC-MS. | ||||
| GC91744 | MDMB-BUTINACA-d9 | - | >99.00% | |
MDMB-BUTINACA-d9 is intended for use as an internal standard for the quantification of MDMB-BUTINACA by GC- or LC-MS. | ||||
| GC91750 | MDMB-4en-PINACA-d4 (CRM) | - | - | |
MDMB-4en-PINACA-d4 (CRM) is intended for use as an internal standard for the quantification of MDMB-4en-PINACA in a drug discrimination test and induces hypothermia in mice. | ||||
| GC91752 | Iloprost-d4 | - | >99.00% | |
Iloprost-d4 is intended for use as an internal standard for the quantification of iloprost by GC- or LC-MS. | ||||
| GC91755 | MDMB-PICA-d9 | - | >99.00% | |
MDMB-PICA-d9 is intended for use as an internal standard for the quantification of MDMB-PICA by GC- or LC-MS. | ||||
| GC91756 | Prednisolone-d7 | - | >99.00% | |
Prednisolone-d7 is intended for use as an internal standard for the quantification of prednisolone by GC- or LC-MS. | ||||